Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...

Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire ...

A 63-year-old woman underwent a complex eight-hour surgery at Pune's Jupiter Hospital, where doctors removed a rare, benign ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Diet influences personality through gut health, neuroplasticity, metabolism, and inflammation, with potential influence on ...

Meet Harvard-trained neuroscientist, Cape Cod writer Lisa Genova, ('Still Alice,') in East Sandwich as she explores bipolar ...

An effective way to help someone with depression is to take their mind off of cyclical thoughts and feelings. Learn how to ...

Light can also affect mood and mental health as the seasons change. During autumn and winter, symptoms such as low mood and ...

Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing ...